These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9012678)

  • 1. Synergism of constitutive activity in alpha 1-adrenergic receptor activation.
    Hwa J; Gaivin R; Porter JE; Perez DM
    Biochemistry; 1997 Jan; 36(3):633-9. PubMed ID: 9012678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
    Zhao MM; Hwa J; Perez DM
    Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of a lysine 331 counterion on the pK(a) of aspartic acid 125: evidence for a salt-bridge interaction and role in alpha(1b)-adrenergic receptor activation.
    Porter JE; Perez DM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):440-8. PubMed ID: 10604981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation.
    Scheer A; Costa T; Fanelli F; De Benedetti PG; Mhaouty-Kodja S; Abuin L; Nenniger-Tosato M; Cotecchia S
    Mol Pharmacol; 2000 Feb; 57(2):219-31. PubMed ID: 10648631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.
    Perez DM; Hwa J; Gaivin R; Mathur M; Brown F; Graham RM
    Mol Pharmacol; 1996 Jan; 49(1):112-22. PubMed ID: 8569696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation.
    Chen S; Lin F; Xu M; Hwa J; Graham RM
    EMBO J; 2000 Aug; 19(16):4265-71. PubMed ID: 10944109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
    Pauwels PJ; Gouble A; Wurch T
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.
    Scheer A; Fanelli F; Costa T; De Benedetti PG; Cotecchia S
    EMBO J; 1996 Jul; 15(14):3566-78. PubMed ID: 8670860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding, partial agonism, and potentiation of alpha(1)-adrenergic receptor function by benzodiazepines: A potential site of allosteric modulation.
    Waugh DJ; Gaivin RJ; Damron DS; Murray PA; Perez DM
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1164-71. PubMed ID: 10565838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
    Egan CT; Herrick-Davis K; Teitler M
    J Pharmacol Exp Ther; 1998 Jul; 286(1):85-90. PubMed ID: 9655845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activity and inverse agonism at the alpha1adrenoceptors.
    Cotecchia S
    Biochem Pharmacol; 2007 Apr; 73(8):1076-83. PubMed ID: 17125741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ligand-receptor-G-protein ternary complex as a GTP-synthase. steady-state proton pumping and dose-response relationships for beta -adrenoceptors.
    Broadley KJ; Nederkoorn PH; Timmerman H; Timms D; Davies RH
    J Theor Biol; 2000 Jul; 205(2):297-320. PubMed ID: 10873440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists.
    Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW
    Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of residues adjacent to transmembrane prolines alters D1 dopamine receptor binding and signal transduction.
    Cho W; Taylor LP; Akil H
    Mol Pharmacol; 1996 Nov; 50(5):1338-45. PubMed ID: 8913366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1B-adrenoceptor interacts with multiple sites of transglutaminase II: characteristics of the interaction in binding and activation.
    Feng JF; Gray CD; Im MJ
    Biochemistry; 1999 Feb; 38(7):2224-32. PubMed ID: 10026307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor.
    Liapakis G; Chan WC; Papadokostaki M; Javitch JA
    Mol Pharmacol; 2004 May; 65(5):1181-90. PubMed ID: 15102946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeras of alpha1-adrenergic receptor subtypes identify critical residues that modulate active state isomerization.
    Hwa J; Graham RM; Perez DM
    J Biol Chem; 1996 Apr; 271(14):7956-64. PubMed ID: 8626475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activity and inverse agonism at the α(₁a) and α(₁b) adrenergic receptor subtypes.
    Cotecchia S
    Methods Enzymol; 2010; 485():123-38. PubMed ID: 21050914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor.
    Alewijnse AE; Timmerman H; Jacobs EH; Smit MJ; Roovers E; Cotecchia S; Leurs R
    Mol Pharmacol; 2000 May; 57(5):890-8. PubMed ID: 10779371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.